Cargando…

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure

Although heart failure due to a wide variety of pathological stimuli including myocardial infarction, pressure overload and volume overload is associated with cardiac hypertrophy, the exact reasons for the transition of cardiac hypertrophy to heart failure are not well defined. Since circulating lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Anureet K., Bhullar, Sukhwinder K., Elimban, Vijayan, Dhalla, Naranjan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228897/ https://www.ncbi.nlm.nih.gov/pubmed/34201261 http://dx.doi.org/10.3390/antiox10060931

Ejemplares similares

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
por: Bhullar, Sukhwinder K., et al.
Publicado: (2022)

Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure
por: Bhullar, Sukhwinder K., et al.
Publicado: (2023)

β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)

Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease
por: Dhalla, Naranjan S., et al.
Publicado: (2022)

Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction
por: Babick, Andrea, et al.
Publicado: (2012)

Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury
por: Dhalla, Naranjan S., et al.
Publicado: (2022)

Role of Oxidative Stress in the Genesis of Ventricular Arrhythmias
por: Adameova, Adriana, et al.
Publicado: (2020)

Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy
por: Dhalla, Naranjan S., et al.
Publicado: (2020)

Reduction of blood pressure by store‐operated calcium channel blockers
por: Xu, Yan‐Jun, et al.
Publicado: (2015)

Modification of Ischemia/Reperfusion-Induced Alterations in Subcellular Organelles by Ischemic Preconditioning
por: Tappia, Paramjit S., et al.
Publicado: (2022)

Effectiveness of Some Vitamins in the Prevention of Cardiovascular Disease: A Narrative Review
por: Shah, Anureet K., et al.
Publicado: (2021)

Suppression of high lipid diet induced by atherosclerosis sarpogrelate
por: Xu, Yan-Jun, et al.
Publicado: (2012)

Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
por: Müller, By Alison L, et al.
Publicado: (2010)

Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure
por: Sanganalmath, Santosh K, et al.
Publicado: (2008)

Protein Kinases as Drug Development Targets for Heart Disease Therapy
por: Dhalla, Naranjan S., et al.
Publicado: (2010)

Interplay of Oxidative Stress and Necrosis-like Cell Death in Cardiac Ischemia/Reperfusion Injury: A Focus on Necroptosis
por: Adameova, Adriana, et al.
Publicado: (2022)

Epigenetics in Cardiac Hypertrophy and Heart Failure
por: Liu, Chia-Feng, et al.
Publicado: (2019)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
por: Tran, Diem H., et al.
Publicado: (2019)

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
por: Hedayati, Neda, et al.
Publicado: (2023)

Mechanisms of the lysophosphatidic acid-induced increase in [Ca(2+)](i) in skeletal muscle cells
por: Xu, Yan-Jun, et al.
Publicado: (2008)

Role and mechanism of cardiac insulin resistance in occurrence of heart failure caused by myocardial hypertrophy
por: Zheng, Liling, et al.
Publicado: (2019)

Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca(2+)-paradox rat hearts
por: Kovács, Árpád, et al.
Publicado: (2017)

Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
por: Tappia, Paramjit S., et al.
Publicado: (2022)

Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
por: Liu, Yonggang, et al.
Publicado: (2013)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
por: Donelson, Jimmonique, et al.
Publicado: (2019)

Oxidative Stress and Heart Failure in Altered Thyroid States
por: Mishra, Pallavi, et al.
Publicado: (2012)

Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
por: Campos, Luciana Aparecida, et al.
Publicado: (2012)

Reciprocal regulation of transcription factors and PLC isozyme gene expression in adult cardiomyocytes
por: Singal, Tushi, et al.
Publicado: (2010)

KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression
por: Tang, Xinmiao, et al.
Publicado: (2022)

Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure
por: Nagai-Okatani, Chiaki, et al.
Publicado: (2016)

Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure
por: Prado, Fernanda P., et al.
Publicado: (2017)

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
por: Polo, Jorge Melero, et al.
Publicado: (2023)

Impaired Cardiac Sympathetic Innervation Increases the Risk of Cardiac Events in Heart Failure Patients with Left Ventricular Hypertrophy and Mechanical Dyssynchrony
por: Doi, Takahiro, et al.
Publicado: (2021)

Alterations of Lipid Metabolism in the Heart in Spontaneously Hypertensive Rats Precedes Left Ventricular Hypertrophy and Cardiac Dysfunction
por: Bednarski, Tomasz K., et al.
Publicado: (2022)

Oxidative Stress, Kinase Activity and Inflammatory Implications in Right Ventricular Hypertrophy and Heart Failure under Hypobaric Hypoxia
por: Pena, Eduardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_omfnfjlcsomu4ccjrliivu7nc3